Joseph A. Pierro
Directeur Technique/Scientifique/R&D chez BioMedical Systems Corp.
Profil
Dr. Joseph A.
Pierro, MD, is Independent Director at FluoroPharma Medical, Inc. and Chief Medical Officer at BioMedical Systems Corp.
He is on the Board of Directors at FluoroPharma Medical, Inc.
He received his undergraduate degree from Canisius College and a doctorate degree from New York University.
Postes actifs de Joseph A. Pierro
| Sociétés | Poste | Début |
|---|---|---|
BioMedical Systems Corp.
 BioMedical Systems Corp. Medical/Nursing ServicesHealth Services BioMedical Systems Corp. provides centralized diagnostic services to pharmaceutical and medical industries. It offers cardiac modalities, including digital 12-lead electrocardiogram (ECG), TQT/intensive studies, Holter monitoring, ambulatory blood pressure monitoring, and ECG stress testing. The firm also centralizes pulmonary function testing in pharmaceutical and medical device clinical trials for the modalities, including spirometry, peak flow with eDiary, challenge testing, pulse oximetry, nitric oxide, and DLco/lung volumes. The company was founded by W. Raymond Barrett in 1975 and is headquartered in St. Louis, MO. | Directeur Technique/Scientifique/R&D | 01/07/2012 |
Anciens postes connus de Joseph A. Pierro
| Sociétés | Poste | Fin |
|---|---|---|
| FLUOROPHARMA MEDICAL, INC. | Directeur/Membre du Conseil | 12/11/2015 |
Formation de Joseph A. Pierro
| New York University | Doctorate Degree |
| Canisius College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FLUOROPHARMA MEDICAL, INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
BioMedical Systems Corp.
BioMedical Systems Corp. Medical/Nursing ServicesHealth Services BioMedical Systems Corp. provides centralized diagnostic services to pharmaceutical and medical industries. It offers cardiac modalities, including digital 12-lead electrocardiogram (ECG), TQT/intensive studies, Holter monitoring, ambulatory blood pressure monitoring, and ECG stress testing. The firm also centralizes pulmonary function testing in pharmaceutical and medical device clinical trials for the modalities, including spirometry, peak flow with eDiary, challenge testing, pulse oximetry, nitric oxide, and DLco/lung volumes. The company was founded by W. Raymond Barrett in 1975 and is headquartered in St. Louis, MO. | Health Services |
